全体要約
地域別では、2022年に北米が主要なシェアを占め、アジア太平洋地域はパーソナライズ治療の認知拡大や新たな市場プレーヤーの登場により、急速に成長する可能性があります。主要企業には、Bachem Holding AG（スイス）、Thermo Fisher Scientific, Inc.（米国）、Merck KGaA（ドイツ）、GenScript Biotech Corporation（中国）などがあります。これらの企業は、ペプチド合成市場の競争環境を形成しており、今後の市場動向に注目が集まります。
関連する質問
859百万 USD（2028年）
7.4%（2023年から2028年）
Bachem Holding AG, Thermo Fisher Scientific, Inc., Merck KGaA, GenScript Biotech Corporation, Kaneka Corporation, Biotage AB, Syngene International Ltd., Mesa Laboratories Inc., CEM Corporation, ProteoGenix, Bio-Synthesis Inc., Dalton Pharma Services, AAPPTec, vivitide, AnyGen Co., Ltd., CSBio, Advanced Chemtech, Luxembourg Bio Technologies Ltd., JPT Peptide Technologies GmbH, AmbioPharm Inc., Aurigene Pharmaceutical Services Ltd., Corden Pharma International, ChemPep Inc., CPC Scientific Inc., Purolite Pvt Ltd.
ペプチド医薬品におけるペプチドの利用増加、研究活動の増加とR&D資金の利用可能性、高度自動化ペプチド合成器の開発
概要
「試薬セグメントは、製品とサービス別でペプチド合成市場において予測期間中に最も高い成長率を占めました。」
2022年に、試薬セグメントは最高の成長率を占めました。ペプチド合成試薬市場は、樹脂、アミノ酸、結合試薬、染料および蛍光標識試薬、その他の試薬（保護試薬、リンカー、バッファー、溶媒、および溶液など）にさらに細分化されます。試薬の大量需要、治療薬、薬物設計、遺伝子合成におけるペプチドの応用拡大は、セグメントの成長を促すと予測される要因の一部です。
「アジア太平洋地域はより速いペースで成長する可能性があります。」
ペプチド合成市場は、北米、ヨーロッパ、アジア太平洋地域、ラテンアメリカ、中東およびアフリカに分かれています。2022年には、北米がペプチド合成市場の主要なシェアを占めました。この地域の優位性は、地域内の主要プレーヤーの存在や、新しい標的治療法の開発に関する研究活動が進行していることに起因しています。アジア太平洋地域は、個別化医療への認識の高まり、地域内でのジェネリック医薬品に関する政府の取り組みの増加、新しい市場プレーヤーの出現などの要因により、より早いペースで成長する見込みです。
このレポートのために実施された主なインタビューは以下のように分類できます。
• 回答者別：供給サイド - 70%、需要サイド - 30%
• 職位別（供給側）：マネージャー - 45%、CXOおよびディレクター - 30%、エグゼクティブ - 25%
地域別：北米 -40%、ヨーロッパ -25%、アジア太平洋 -20%、ラテンアメリカ -10%、中東およびアフリカ -5%
報告書に掲載されている企業のリスト：
• バッヘム・ホールディングAG（スイス）
サーモフィッシャーサイエンティフィック社 (米国)
• メルクKGaA（ドイツ）
・GENSCRIPTバイオテック株式会社（中国）
カネカ株式会社（日本）
ビオテージ AB（スウェーデン）
シンジェンインターナショナル株式会社（インド）
メサラボラトリーズ社（アメリカ）
• CEMコーポレーション（アメリカ）
プロテオジェニクス（フランス）
バイオシンセシス社 (アメリカ)
・ダルトンファーマサービス（カナダ）
AAPPTec（米国）
・ビビタイド（アメリカ）
エニジェン株式会社（韓国）
• CSBio（アメリカ）
アドバンスト・ケムテック（米国）
• ルクセンブルク・バイオテクノロジーズ・リミテッド（イスラエル）
JPTペプチドテクノロジーズ GmbH（ドイツ）
• アンビオファーム株式会社 (アメリカ)
・オーリジェンファーマシューティカルサービス株式会社（インド）
コーデンファーマインターナショナル（ドイツ）
・ChemPep株式会社（アメリカ）
CPCサイエンティフィック株式会社（アメリカ）
• プロライテ Pvt Ltd.（アメリカ）
調査範囲：
この報告書はペプチド合成市場の詳細な状況を提供します。市場の規模と将来の成長可能性を製品、アプリケーション、エンドユーザー、地域などのさまざまなセグメントにわたって推定することを目的としています。また、報告書には主要市場プレーヤーの詳細な競争分析および彼らの企業プロフィール、最近の開発、重要な市場戦略も含まれています。
レポート購入の主な利点：
このレポートは、市場のリーダーや新規参入者が、全体的なペプチド合成市場およびそのサブセグメントの収益数値に最も近い推定値を提供することで、役立ちます。また、ステークホルダーが競争環境をよりよく理解し、自社をより良く位置づけ、それに適した市場進出戦略を立てるための洞察を得る手助けをします。このレポートは、ステークホルダーが市場の動向を理解し、主要な市場の推進要因、制約要因、機会、課題に関する情報を提供することを可能にします。
報告書は以下のポイントに関する洞察を提供します：
• 主要な推進要因の分析（医薬品におけるペプチドの使用増加、研究活動の増加とR&Dのための資金の利用可能性、先進的な自動ペプチド合成機の開発）、制約（治療用ペプチドに対する統一された規制の欠如、高コストの装置）、機会（アジア太平洋地域の新興市場、個別化医療の開発）、および課題（ペプチド薬剤の投与経路に関連する問題、ペプチドの化学合成による環境影響への対処）。
• 製品・サービスの開発/イノベーション：新しく発売された製品に関する詳細な洞察と、ペプチド合成市場の技術評価。
市場開発：収益性のある市場に関する包括的な情報 - このレポートでは、さまざまな地域にわたるペプチド合成市場を分析しています。
市場の多様化: ペプチド合成市場における新製品とサービス、未開拓地域、最近の動向、そして投資に関する詳細情報です。
• 競争評価：ペプチド合成市場における中国のGenScript Biotech Corporation、アメリカのThermo Fisher Scientific, Inc.、スイスのBachem Holding AG、アメリカのKaneka Corporation、ドイツのMerck KGaAなどのリーディングプレイヤーの市場シェア、成長戦略、製品およびサービスの提供についての詳細な評価です。
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 イントロダクション 34
1.1 調査の目的 34
1.2 市場の定義 34
1.2.1 包含・除外事項 34
1.3 市場範囲 35
1.3.1 対象市場 35
1.3.2 対象年 35
1.4 通貨 36
1.5 制約 36
1.6 ステークホルダー 36
1.7 変化のサマリー 37
1.7.1 リセッション時のインパクト 37
2 調査手法 38
2.1 リサーチデータ 38
2.1.1 二次データ 39
2.1.2 一次データ 40
2.2 市場規模予測 41
2.2.1 プライマリーからの洞察 44
2.2.2 セグメント評価（製品別、用途別、エンドユーザー別） 44
2.3 成長率の前提 45
2.4 市場の内訳とデータのトライアンギュレーション 47
2.5 調査の前提 48
2.6 リスク分析 48
2.7 ペプチド合成市場への景気後退の影響 48
3 エグゼクティブサマリー 50
4 更なる考察 53
4.1 ペプチド合成市場の概要 53
4.2 北米のペプチド合成市場：製品・サービス別、国別（2022年） 54
4.3 ペプチド合成市場の技術別シェア（2022年） 54
4.4 ペプチド合成市場、エンドユーザー別、2023年 vs 2028年（百万米ドル） 55
4.5 ペプチド合成市場、地理的側面での成長機会 56
5 市場概要 57
5.1 イントロダクション 57
5.2 市場力学 57
5.2.1 促進要因 58
- 5.2.1.1 医薬品におけるペプチドの使用の増加 58
- 5.2.1.2 研究活動の増加と研究開発資金の確保 61
- 5.2.1.3 高度な自動ペプチド合成機の開発 62
5.2.2 抑制要因 63
- 5.2.2.1 治療用ペプチドに関する統一された規制の欠如 63
- 5.2.2.2 楽器が高い 63
5.2.3 市場機会 64
- 5.2.3.1 アジア太平洋地域の新興市場 64
- 5.2.3.2 個別化医薬品の開発 64
5.2.4 課題 65
- 5.2.4.1 ペプチド医薬品の投与経路に関する問題点 65
- 5.2.4.2 ペプチド化学合成の環境負荷への対応 65
5.3 レンジ/シナリオ 66
5.4 顧客事業にインパクトのあるトレンド/ディスラプション 67
5.5 バリューチェーン分析 67
5.6 技術分析 68
5.7 特許分析 69
5.8 ペプチド合成市場のエコシステム分析 72
5.9 ポーターのファイブフォース分析 74
5.9.1 新規参入の脅威 74
5.9.2 代替品の脅威 74
5.9.3 サプライヤーの交渉力 74
5.9.4 買い手の交渉力 75
5.9.5 競合・競争状況の激しさ 75
5.10 規制分析 75
5.10.1 ペプチド医薬品に関する規制 75
5.10.2 ペプチド合成製品に関する規制 75
5.10.3 規制当局、政府機関、その他組織 76
5.11 2023年の主な会議・イベント 79
5.12 主なステークホルダーと購入基準 79
5.12.1 購買プロセスにおける主要ステークホルダー 79
5.12.2 購買基準 80
6 ペプチド合成市場、製品・サービス別 81
6.1 イントロダクション 82
6.2 試薬 82
6.2.1 樹脂 85
- 6.2.1.1 固相ペプチド合成技術の採用増加が市場を押し上げる 85
6.2.2 アミノ酸 87
- 6.2.2.1 アミノ酸はペプチド合成に重要な役割を果たす 87
6.2.3 カップリング試薬 89
6.2.4 色素・蛍光標識試薬 92
6.2.5 その他試薬 95
6.3 設備 97
6.3.1 ペプチドシンセサイザー 100
- 6.3.1.1 ペプチド合成機の自動化の進展が市場成長を促進 100
6.3.2 クロマトグラフィー設備 103
6.3.3 凍結乾燥機 106
6.4 サービス 108
7 ペプチド合成の市場、技術別 111
7.1 イントロダクション 112
7.2 固相ペプチド合成 112
7.3 溶液相ペプチド合成法 115
7.4 ハイブリッド＆リコンビナントテクノロジー 118
7.4.1 高複雑度ペプチドの生産が市場を押し上げる 118
8 ペプチド合成の市場、エンドユーザー別 122
8.1 イントロダクション 123
8.2 製薬会社・バイオテクノロジー企業 123
8.2.1 医薬品開発におけるペプチドの利用が成長を促進 123
8.3 開発・製造受託機関および開発業務受託機関（cdmos および Cros） 126
8.3.1 費用対効果の高いペプチド合成サービスへの需要増加が成長を牽引 126
8.4 学術・研究機関 129
9 ペプチド合成の市場、地域別 133
9.1 イントロダクション 134
9.2 北米 134
9.2.1 米国 138
9.2.2 カナダ 140
- 9.2.2.1 カナダにおける研究費の確保が市場成長を促進 140
9.3 ヨーロッパ 142
9.3.1 ドイツ 145
9.3.2 英国 148
- 9.3.2.1 ライフサイエンス研究の発展が市場成長を牽引 148
9.3.3 フランス 150
9.3.4 イタリア 152
9.3.5 スペイン 155
- 9.3.5.1 市場成長を支える研究・技術革新への注目度上昇 155
9.3.6 その他ヨーロッパ 157
9.4 アジア太平洋 160
9.4.1 中国 164
9.4.2 日本 167
9.4.3 インド 169
- 9.4.3.1 科学研究に対する政府のサポートが市場成長を促進 169
9.4.4 韓国 171
- 9.4.4.1 バイオ医薬品分野での研究努力の高まりが市場成長を後押し 171
9.5 その他アジア太平洋 173
9.6 ラテンアメリカ 176
9.6.1 ブラジル 178
- 9.6.1.1 政府による研究投資の増加が市場成長を促進 178
9.6.2 メキシコ 180
- 9.6.2.1 合成生物学研究の進展が市場成長を牽引 180
9.6.3 その他ラテンアメリカ 182
9.6.4 中東・アフリカ 184
10 競合情勢 187
10.1 イントロダクション 187
10.2 主要プレイヤーの戦略 188
10.3 REVENUE SHARE ANALYSIS 189
10.4 市場シェア分析 189
10.5 企業評価マトリックス：主要企業 191
10.5.1 STARS 192
10.5.2 EMERGING LEADERS 192
10.5.3 PERVASIVE PLAYERS 193
10.5.4 PARTICIPANTS 193
10.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS 193
10.6.1 各社の製品フットプリント（25社） 193
10.6.2 企業の地域フットプリント（25社） 194
10.7 COMPANY EVALUATION QUADRANT: START-UPS/SMES 196
10.7.1 PROGRESSIVE COMPANIES 197
10.7.2 STARTING BLOCKS 197
10.7.3 RESPONSIVE COMPANIES 197
10.7.4 DYNAMIC COMPANIES 197
10.8 COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS 197
10.9 COMPETITIVE SCENARIO AND TRENDS 199
10.9.1 製品展開 199
10.9.2 ディール 200
10.9.3 その他の展開 200
11 企業プロファイル 201
11.1 主要企業 201
11.1.1 THERMO FISHER SCIENTIFIC 201
11.1.2 MERCK KGAA 205
11.1.3 GENSCRIPT BIOTECH CORPORATION 209
11.1.4 BACHEM HOLDING AG 213
11.1.5 KANEKA CORPORATION 217
11.1.6 BIOTAGE AB 222
11.1.7 SYNGENE INTERNATIONAL LIMITED 225
11.1.8 MESA LABORATORIES, INC 227
11.1.9 CEM CORPORATION 231
11.1.10 PROTEOGENIX 234
11.1.11 BIO-SYNTHESIS INC 236
11.1.12 DALTON PHARMA SERVICES 238
11.1.13 AAPPTEC 239
11.1.14 VIVITIDE 242
11.1.15 ANYGEN CO., LTD 243
11.2 他の有力企業 244
11.2.1 CSBIO 244
11.2.2 ADVANCED CHEMTECH 245
11.2.3 LUXEMBOURG BIO TECHNOLOGIES LTD 245
11.2.4 JPT PEPTIDE TECHNOLOGIES GMBH 246
11.2.5 AMBIOPHARM INC 246
11.2.6 AURIGENE PHARMACEUTICAL SERVICES LTD 247
11.2.7 CORDENPHARMA INTERNATIONAL 247
11.2.8 CHEMPEP INC 248
11.2.9 CPC SCIENTIFIC INC 249
11.2.10 PUROLITE PVT. LTD 249
12 付録 250
12.1 ディスカッションガイド 250
12.2 ナレッジストア 254
12.3 カスタマイズオプション 256
12.4 関連レポート 256
12.5 執筆者の詳細 257
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
Table of Contents
1 INTRODUCTION 34
1.1 STUDY OBJECTIVES 34
1.2 MARKET DEFINITION 34
1.2.1 INCLUSIONS & EXCLUSIONS 34
1.3 MARKET SCOPE 35
1.3.1 MARKETS COVERED 35
1.3.2 YEARS CONSIDERED 35
1.4 CURRENCY CONSIDERED 36
1.5 LIMITATIONS 36
1.6 STAKEHOLDERS 36
1.7 SUMMARY OF CHANGES 37
1.7.1 RECESSION IMPACT 37
2 RESEARCH METHODOLOGY 38
2.1 RESEARCH DATA 38
2.1.1 SECONDARY DATA 39
2.1.2 PRIMARY DATA 40
2.2 MARKET SIZE ESTIMATION 41
2.2.1 INSIGHTS FROM PRIMARIES 44
2.2.2 SEGMENT ASSESSMENT (BY PRODUCT, APPLICATION, AND END USER) 44
2.3 GROWTH RATE ASSUMPTIONS 45
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 47
2.5 STUDY ASSUMPTIONS 48
2.6 RISK ANALYSIS 48
2.7 IMPACT OF ECONOMIC RECESSION ON PEPTIDE SYNTHESIS MARKET 48
3 EXECUTIVE SUMMARY 50
4 PREMIUM INSIGHTS 53
4.1 PEPTIDE SYNTHESIS MARKET OVERVIEW 53
4.2 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE AND COUNTRY (2022) 54
4.3 PEPTIDE SYNTHESIS MARKET SHARE, BY TECHNOLOGY (2022) 54
4.4 PEPTIDE SYNTHESIS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 55
4.5 PEPTIDE SYNTHESIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS 57
5.2.1 DRIVERS 58
- 5.2.1.1 Increasing use of peptides in pharmaceutical drugs 58
- 5.2.1.2 Increase in research activities and availability of funding for R&D 61
- 5.2.1.3 Development of advanced automated peptide synthesizers 62
5.2.2 RESTRAINTS 63
- 5.2.2.1 Lack of unified set of regulations for therapeutic peptides 63
- 5.2.2.2 High cost of instruments 63
5.2.3 OPPORTUNITIES 64
- 5.2.3.1 Emerging markets in Asia Pacific region 64
- 5.2.3.2 Development of personalized medicines 64
5.2.4 CHALLENGES 65
- 5.2.4.1 Issues associated with route of administration of peptide drugs 65
- 5.2.4.2 Addressing environmental impact of chemical synthesis of peptides 65
5.3 RANGES/SCENARIOS 66
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 67
5.5 VALUE CHAIN ANALYSIS 67
5.6 TECHNOLOGY ANALYSIS 68
5.7 PATENT ANALYSIS 69
5.8 ECOSYSTEM ANALYSIS OF PEPTIDE SYNTHESIS MARKET 72
5.9 PORTER’S FIVE FORCES ANALYSIS 74
5.9.1 THREAT OF NEW ENTRANTS 74
5.9.2 THREAT OF SUBSTITUTES 74
5.9.3 BARGAINING POWER OF SUPPLIERS 74
5.9.4 BARGAINING POWER OF BUYERS 75
5.9.5 INTENSITY OF COMPETITIVE RIVALRY 75
5.10 REGULATORY ANALYSIS 75
5.10.1 REGULATIONS FOR PEPTIDE-BASED DRUGS 75
5.10.2 REGULATIONS FOR PEPTIDE SYNTHESIS PRODUCTS 75
5.10.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76
5.11 KEY CONFERENCES AND EVENTS IN 2023 79
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA 79
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 79
5.12.2 BUYING CRITERIA 80
6 PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE 81
6.1 INTRODUCTION 82
6.2 REAGENTS 82
6.2.1 RESINS 85
- 6.2.1.1 Increasing adoption of solid-phase peptide synthesis technology to boost market 85
6.2.2 AMINO ACIDS 87
- 6.2.2.1 Amino acids play crucial role in synthesis of peptides 87
6.2.3 COUPLING REAGENTS 89
- 6.2.3.1 Vital role of coupling reagents in peptide bond formation to boost market 89
6.2.4 DYES & FLUORESCENT LABELING REAGENTS 92
- 6.2.4.1 Fluorescent labeling reagents play crucial role in understanding success rate of peptide synthesis reactions 92
6.2.5 OTHER REAGENTS 95
6.3 EQUIPMENT 97
6.3.1 PEPTIDE SYNTHESIZERS 100
- 6.3.1.1 Rising automation in peptide synthesizers to drive market growth 100
6.3.2 CHROMATOGRAPHY EQUIPMENT 103
- 6.3.2.1 Reverse-phase HPLC used for purification of synthetic peptides to promote market growth 103
6.3.3 LYOPHILIZERS 106
- 6.3.3.1 Lyophilization to enable longer shelf life and easy transportation of peptides 106
6.4 SERVICES 108
6.4.1 RISE IN RESEARCH ACTIVITIES IN PROTEOMICS, GENOMICS, AND PEPTIDE THERAPEUTICS TO DRIVE MARKET 108
7 PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY 111
7.1 INTRODUCTION 112
7.2 SOLID-PHASE PEPTIDE SYNTHESIS 112
7.2.1 EASE OF USE OF SOLID-PHASE PEPTIDE SYNTHESIS TECHNOLOGY TO DRIVE GROWTH 112
7.3 SOLUTION-PHASE PEPTIDE SYNTHESIS 115
7.3.1 ABILITY TO PRODUCE LARGE QUANTITIES OF HIGH-QUALITY PEPTIDES COST-EFFECTIVELY TO DRIVE GROWTH 115
7.4 HYBRID & RECOMBINANT TECHNOLOGY 118
7.4.1 PRODUCTION OF PEPTIDES WITH HIGH COMPLEXITY TO BOOST MARKET 118
8 PEPTIDE SYNTHESIS MARKET, BY END USER 122
8.1 INTRODUCTION 123
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 123
8.2.1 USE OF PEPTIDES IN DRUG DEVELOPMENT APPLICATIONS TO DRIVE GROWTH 123
8.3 CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS AND CONTRACT RESEARCH ORGANIZATIONS (CDMOS AND CROS) 126
8.3.1 INCREASING DEMAND FOR COST-EFFECTIVE PEPTIDE SYNTHESIS SERVICES TO DRIVE GROWTH 126
8.4 ACADEMIC & RESEARCH INSTITUTES 129
8.4.1 INCREASE IN FINANCIAL AND REGULATORY SUPPORT FOR RESEARCH TO BOOST MARKET GROWTH 129
9 PEPTIDE SYNTHESIS MARKET, BY REGION 133
9.1 INTRODUCTION 134
9.2 NORTH AMERICA 134
9.2.1 US 138
- 9.2.1.1 US to dominate North American peptide synthesis market during forecast period 138
9.2.2 CANADA 140
- 9.2.2.1 Availability of research funding in Canada to drive market growth 140
9.3 EUROPE 142
9.3.1 GERMANY 145
- 9.3.1.1 Government initiatives and rise in funding for peptide synthesis to propel growth 145
9.3.2 UK 148
- 9.3.2.1 Growth in life science research to drive market growth 148
9.3.3 FRANCE 150
- 9.3.3.1 Government funding for proteomics and genomics research to propel market growth 150
9.3.4 ITALY 152
- 9.3.4.1 Increase in life science research to boost market growth in Italy 152
9.3.5 SPAIN 155
- 9.3.5.1 Rising focus on research and innovation to support market growth 155
9.3.6 REST OF EUROPE 157
9.4 ASIA PACIFIC 160
9.4.1 CHINA 164
- 9.4.1.1 China to register highest growth rate due to increase in investments in R&D 164
9.4.2 JAPAN 167
- 9.4.2.1 Rise in collaborations between companies in Japan to propel market growth 167
9.4.3 INDIA 169
- 9.4.3.1 Government support for scientific research to drive market growth 169
9.4.4 SOUTH KOREA 171
- 9.4.4.1 Growing research efforts in biopharmaceutical sector to boost market growth 171
9.5 REST OF ASIA PACIFIC 173
9.6 LATIN AMERICA 176
9.6.1 BRAZIL 178
- 9.6.1.1 Rising government investments in research to propel market growth 178
9.6.2 MEXICO 180
- 9.6.2.1 Synthetic biology research advancements to drive market growth 180
9.6.3 REST OF LATIN AMERICA 182
9.6.4 MIDDLE EAST & AFRICA 184
- 9.6.4.1 Growing pharmaceutical & biotechnology industries and increasing R&D activities to drive market growth 184
10 COMPETITIVE LANDSCAPE 187
10.1 INTRODUCTION 187
10.2 STRATEGIES ADOPTED BY KEY PLAYERS 188
10.3 REVENUE SHARE ANALYSIS 189
10.4 MARKET SHARE ANALYSIS 189
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS 191
10.5.1 STARS 192
10.5.2 EMERGING LEADERS 192
10.5.3 PERVASIVE PLAYERS 193
10.5.4 PARTICIPANTS 193
10.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS 193
10.6.1 PRODUCT FOOTPRINT OF COMPANIES (25 COMPANIES) 193
10.6.2 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES) 194
10.7 COMPANY EVALUATION QUADRANT: START-UPS/SMES 196
10.7.1 PROGRESSIVE COMPANIES 197
10.7.2 STARTING BLOCKS 197
10.7.3 RESPONSIVE COMPANIES 197
10.7.4 DYNAMIC COMPANIES 197
10.8 COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS 197
10.9 COMPETITIVE SCENARIO AND TRENDS 199
10.9.1 PRODUCT LAUNCHES 199
10.9.2 DEALS 200
10.9.3 OTHER DEVELOPMENTS 200
11 COMPANY PROFILES 201
11.1 KEY PLAYERS 201
11.1.1 THERMO FISHER SCIENTIFIC 201
11.1.2 MERCK KGAA 205
11.1.3 GENSCRIPT BIOTECH CORPORATION 209
11.1.4 BACHEM HOLDING AG 213
11.1.5 KANEKA CORPORATION 217
11.1.6 BIOTAGE AB 222
11.1.7 SYNGENE INTERNATIONAL LIMITED 225
11.1.8 MESA LABORATORIES, INC 227
11.1.9 CEM CORPORATION 231
11.1.10 PROTEOGENIX 234
11.1.11 BIO-SYNTHESIS INC 236
11.1.12 DALTON PHARMA SERVICES 238
11.1.13 AAPPTEC 239
11.1.14 VIVITIDE 242
11.1.15 ANYGEN CO., LTD 243
11.2 OTHER PLAYERS 244
11.2.1 CSBIO 244
11.2.2 ADVANCED CHEMTECH 245
11.2.3 LUXEMBOURG BIO TECHNOLOGIES LTD 245
11.2.4 JPT PEPTIDE TECHNOLOGIES GMBH 246
11.2.5 AMBIOPHARM INC 246
11.2.6 AURIGENE PHARMACEUTICAL SERVICES LTD 247
11.2.7 CORDENPHARMA INTERNATIONAL 247
11.2.8 CHEMPEP INC 248
11.2.9 CPC SCIENTIFIC INC 249
11.2.10 PUROLITE PVT. LTD 249
12 APPENDIX 250
12.1 DISCUSSION GUIDE 250
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 254
12.3 CUSTOMIZATION OPTIONS 256
12.4 RELATED REPORTS 256
12.5 AUTHOR DETAILS 257
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021-2028 (% GROWTH) TABLE 2 US HEALTH EXPENDITURE, 2019-2022 (USD MILLION) TABLE 3 US HEALTH EXPENDITURE, 2023-2027 (USD MILLION) TABLE 4 PEPTIDE SYNTHESIS MARKET: IMPACT ANALYSIS TABLE 5 PEPTIDE-BASED DRUGS APPROVED BY FOOD AND DRUG ADMINISTRATION TABLE 6 KEY SYNTHETIC PEPTIDES IN DEVELOPMENT FOR COVID-19 TABLE 7 COMPARISON OF PEPTIDE SYNTHESIS TECHNOLOGIES TABLE 8 INDICATIVE LIST OF PATENTS IN PEPTIDE SYNTHESIS MARKET TABLE 9 SUPPLY CHAIN ECOSYSTEM TABLE 10 PEPTIDE SYNTHESIS MARKET: PORTER’S FIVE FORCES ANALYSIS TABLE 11 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS TABLE 12 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS TABLE 13 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS TABLE 14 PEPTIDE SYNTHESIS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2023 TABLE 15 PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 16 PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 17 PEPTIDE SYNTHESIS REAGENTS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 18 NORTH AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 19 EUROPE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 20 ASIA PACIFIC: PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 21 LATIN AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 22 PEPTIDE SYNTHESIS MARKET FOR RESINS, BY REGION, 2021-2028 (USD MILLION) TABLE 23 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR RESINS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 24 EUROPE: PEPTIDE SYNTHESIS MARKET FOR RESINS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 25 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR RESINS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 26 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR RESINS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 27 PEPTIDE SYNTHESIS MARKET FOR AMINO ACIDS, BY REGION, 2021-2028 (USD MILLION) TABLE 28 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR AMINO ACIDS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 29 EUROPE: PEPTIDE SYNTHESIS MARKET FOR AMINO ACIDS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 30 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR AMINO ACIDS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 31 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR AMINO ACIDS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 32 PEPTIDE SYNTHESIS MARKET FOR COUPLING REAGENTS, BY REGION, 2021-2028 (USD MILLION) TABLE 33 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR COUPLING REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 34 EUROPE: PEPTIDE SYNTHESIS MARKET FOR COUPLING REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 35 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR COUPLING REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 36 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR COUPLING REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 37 PEPTIDE SYNTHESIS MARKET FOR DYES & FLUORESCENT LABELING REAGENTS, BY REGION, 2021-2028 (USD MILLION) TABLE 38 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR DYES & FLUORESCENT LABELING REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 39 EUROPE: PEPTIDE SYNTHESIS MARKET FOR DYES & FLUORESCENT LABELING REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 40 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR DYES & FLUORESCENT LABELING REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 41 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR DYES & FLUORESCENT LABELING REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 42 PEPTIDE SYNTHESIS MARKET FOR OTHER REAGENTS, BY REGION, 2021-2028 (USD MILLION) TABLE 43 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 44 EUROPE: PEPTIDE SYNTHESIS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 45 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 46 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 47 PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 48 PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 49 NORTH AMERICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 50 EUROPE: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 51 ASIA PACIFIC: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 52 LATIN AMERICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 53 MAJOR PEPTIDE SYNTHESIZERS AVAILABLE IN MARKET TABLE 54 PEPTIDE SYNTHESIS MARKET FOR PEPTIDE SYNTHESIZERS, BY REGION, 2021-2028 (USD MILLION) TABLE 55 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE SYNTHESIZERS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 56 EUROPE: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE SYNTHESIZERS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 57 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE SYNTHESIZERS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 58 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE SYNTHESIZERS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 59 PEPTIDE SYNTHESIS MARKET FOR CHROMATOGRAPHY EQUIPMENT, BY REGION, 2021-2028 (USD MILLION) TABLE 60 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR CHROMATOGRAPHY EQUIPMENT, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 61 EUROPE: PEPTIDE SYNTHESIS MARKET FOR CHROMATOGRAPHY EQUIPMENT, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 62 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR CHROMATOGRAPHY EQUIPMENT, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 63 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR CHROMATOGRAPHY EQUIPMENT, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 64 PEPTIDE SYNTHESIS MARKET FOR LYOPHILIZERS, BY REGION, 2021-2028 (USD MILLION) TABLE 65 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR LYOPHILIZERS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 66 EUROPE: PEPTIDE SYNTHESIS MARKET FOR LYOPHILIZERS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 67 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR LYOPHILIZERS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 68 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR LYOPHILIZERS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 69 PEPTIDE SYNTHESIS SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 70 NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 71 EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 72 ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 73 LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 74 PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 75 SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 76 NORTH AMERICA: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 77 EUROPE: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 78 ASIA PACIFIC: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 79 LATIN AMERICA: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 80 SOLUTION-PHASE PEPTIDE SYNTHESIS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 81 NORTH AMERICA: SOLUTION-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 82 EUROPE: SOLUTION-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 83 ASIA PACIFIC: SOLUTION-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 84 LATIN AMERICA: SOLUTION-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 85 HYBRID & RECOMBINANT PEPTIDE SYNTHESIS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 86 NORTH AMERICA: HYBRID & RECOMBINANT PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 87 EUROPE: HYBRID & RECOMBINANT PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 88 ASIA PACIFIC: HYBRID & RECOMBINANT PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 89 LATIN AMERICA: HYBRID & RECOMBINANT PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 90 PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 91 PEPTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2028 (USD MILLION) TABLE 92 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 93 EUROPE: PEPTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 94 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 95 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 96 PEPTIDE SYNTHESIS MARKET FOR CDMOS AND CROS, BY REGION, 2021-2028 (USD MILLION) TABLE 97 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR CDMOS AND CROS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 98 EUROPE: PEPTIDE SYNTHESIS MARKET FOR CDMOS AND CROS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 99 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR CDMOS AND CROS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 100 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR CDMOS AND CROS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 101 PEPTIDE SYNTHESIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021-2028 (USD MILLION) TABLE 102 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 103 EUROPE: PEPTIDE SYNTHESIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 104 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 105 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 106 PEPTIDE SYNTHESIS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 107 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 108 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 109 NORTH AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 110 NORTH AMERICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 111 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 112 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 113 US: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 114 US: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 115 US: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 116 US: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 117 US: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 118 CANADA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 119 CANADA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 120 CANADA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 121 CANADA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 122 CANADA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 123 EUROPE: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 124 EUROPE: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 125 EUROPE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 126 EUROPE: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 127 EUROPE: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 128 EUROPE: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 129 GERMANY: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 130 GERMANY: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 131 GERMANY: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 132 GERMANY: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 133 GERMANY: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 USD MILLION) TABLE 134 UK: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 135 UK: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 136 UK: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 137 UK: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 138 UK: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 139 FRANCE: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 140 FRANCE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 141 FRANCE: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 142 FRANCE: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 143 FRANCE: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 144 ITALY: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 145 ITALY: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 146 ITALY: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 147 ITALY: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 148 ITALY: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 USD MILLION) TABLE 149 SPAIN: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 150 SPAIN: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 151 SPAIN: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 152 SPAIN: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 153 SPAIN: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 USD MILLION) TABLE 154 REST OF EUROPE: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 155 REST OF EUROPE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 156 REST OF EUROPE: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 157 REST OF EUROPE: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 158 REST OF EUROPE: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 159 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 160 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 161 ASIA PACIFIC: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 162 ASIA PACIFIC: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 163 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 164 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 165 CHINA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 166 CHINA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 167 CHINA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 168 CHINA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 169 CHINA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 170 JAPAN: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 171 JAPAN: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 172 JAPAN: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 173 JAPAN: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 174 JAPAN: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 175 INDIA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 176 INDIA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 177 INDIA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 178 INDIA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 179 INDIA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 180 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 181 SOUTH KOREA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 182 SOUTH KOREA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 183 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 184 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 185 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 186 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 187 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 188 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 189 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 190 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 191 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 192 LATIN AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 193 LATIN AMERICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 194 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 195 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 196 BRAZIL: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 197 BRAZIL: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 198 BRAZIL: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 199 BRAZIL: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 200 BRAZIL: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 201 MEXICO: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 202 MEXICO: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 203 MEXICO: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 204 MEXICO: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 205 MEXICO: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 206 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 207 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 208 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 209 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 210 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 211 MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION) TABLE 212 MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 213 MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 214 MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 215 MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 216 PEPTIDE SYNTHESIS MARKET: DEGREE OF COMPETITION TABLE 217 PEPTIDE SYNTHESIS MARKET: PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS TABLE 218 PEPTIDE SYNTHESIS MARKET: REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS TABLE 219 PEPTIDE SYNTHESIS MARKET: DETAILED LIST OF KEY START-UP/SME PLAYERS TABLE 220 PEPTIDE SYNTHESIS MARKET: COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS TABLE 221 PEPTIDE SYNTHESIS MARKET: PRODUCT LAUNCHES, JANUARY 2020-JUNE 2023 TABLE 222 PEPTIDE SYNTHESIS MARKET: DEALS, JANUARY 2020-JUNE 2023 TABLE 223 PEPTIDE SYNTHESIS MARKET: OTHER DEVELOPMENTS, JANUARY 2020-JUNE 2023 TABLE 224 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW TABLE 225 MERCK KGAA: BUSINESS OVERVIEW TABLE 226 GENSCRIPT BIOTECH CORPORATION: BUSINESS OVERVIEW TABLE 227 BACHEM HOLDING AG: BUSINESS OVERVIEW TABLE 228 KANEKA CORPORATION: BUSINESS OVERVIEW TABLE 229 BIOTAGE AB: BUSINESS OVERVIEW TABLE 230 SYNGENE INTERNATIONAL LIMITED: BUSINESS OVERVIEW TABLE 231 MESA LABORATORIES, INC.: BUSINESS OVERVIEW TABLE 232 CEM CORPORATION: BUSINESS OVERVIEW TABLE 233 PROTEOGENIX: BUSINESS OVERVIEW TABLE 234 BIO-SYNTHESIS INC.: BUSINESS OVERVIEW TABLE 235 DALTON PHARMA SERVICES: BUSINESS OVERVIEW TABLE 236 AAPPTEC: BUSINESS OVERVIEW TABLE 237 VIVITIDE: BUSINESS OVERVIEW TABLE 238 ANYGEN CO., LTD.: BUSINESS OVERVIEW
FIGURE 1 RESEARCH DESIGN FIGURE 2 PEPTIDE SYNTHESIS MARKET: BREAKDOWN OF PRIMARIES FIGURE 3 PEPTIDE SYNTHESIS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2022 FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022 FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE ANALYSIS, 2022 FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH FIGURE 8 PEPTIDE SYNTHESIS MARKET: CAGR PROJECTIONS, 2023-2028 FIGURE 9 PEPTIDE SYNTHESIS MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES FIGURE 10 DATA TRIANGULATION METHODOLOGY FIGURE 11 PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION) FIGURE 12 PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION) FIGURE 13 PEPTIDE SYNTHESIS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) FIGURE 14 PEPTIDE SYNTHESIS MARKET: GEOGRAPHICAL SNAPSHOT FIGURE 15 INCREASING USE OF PEPTIDES IN PHARMACEUTICAL DRUGS AND GROWING RESEARCH ACTIVITIES TO DRIVE MARKET GROWTH FIGURE 16 REAGENTS SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN PEPTIDE SYNTHESIS MARKET IN 2022 FIGURE 17 SOLID-PHASE PEPTIDE SYNTHESIS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES WILL CONTINUE TO DOMINATE MARKET IN 2028 FIGURE 19 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD FIGURE 20 MARKET DYNAMICS: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FIGURE 21 RISE IN GLOBAL PHARMACEUTICAL R&D SPENDING, 2012-2026 FIGURE 22 SPECTRUM OF SCENARIOS BASED ON IMPACT OF UNCERTAINTIES ON GROWTH OF PEPTIDE SYNTHESIS MARKET FIGURE 23 VALUE CHAIN ANALYSIS OF PEPTIDE SYNTHESIS MARKET: RESEARCH AND MANUFACTURING PHASE CONTRIBUTES MAXIMUM VALUE FIGURE 24 PATENT APPLICATIONS FOR PEPTIDE SYNTHESIS MARKET, JUNE 2013-JUNE 2023 FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF PEPTIDE SYNTHESIS PRODUCTS FIGURE 26 KEY BUYING CRITERIA FOR END USERS FIGURE 27 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET SNAPSHOT FIGURE 28 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET SNAPSHOT FIGURE 29 PEPTIDE SYNTHESIS MARKET: STRATEGIES ADOPTED BY KEY PLAYERS FIGURE 30 REVENUE ANALYSIS OF KEY PLAYERS, 2020-2022 FIGURE 31 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2022 FIGURE 32 PEPTIDE SYNTHESIS MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022 FIGURE 33 PEPTIDE SYNTHESIS MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022 FIGURE 34 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2022) FIGURE 35 MERCK KGAA: COMPANY SNAPSHOT (2022) FIGURE 36 GENSCRIPT BIOTECH CORPORATION: COMPANY SNAPSHOT (2022) FIGURE 37 BACHEM HOLDING AG: COMPANY SNAPSHOT (2022) FIGURE 38 KANEKA CORPORATION: COMPANY SNAPSHOT (2022) FIGURE 39 BIOTAGE AB: COMPANY SNAPSHOT (2022) FIGURE 40 SYNGENE INTERNATIONAL LIMITED: COMPANY SNAPSHOT (2022) FIGURE 41 MESA LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
